Anil Rajendra, MD
Clinical Cardiac Electrophysiology · Birmingham, ALNPI 1376740589
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Boston Scientific at 33.3% of the total. Among clinical cardiac electrophysiology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,043 payments — averaging $474.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$165K
- Medical Device Business Services, Inc.$98K
- Acutus Medical, Inc.$71K
- Philips North America LLC$41K
- Biosense Webster, Inc.$37K
- Cardiofocus, Inc.$25K
- plus $58K from 25 others
Across 308 payments — averaging $4514.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$509K
- Boston Scientific$338K
- Biosense Webster, Inc.$266K
- Cortex, Inc.$107K
- Abbott$69K
- Medical Device Business Services, Inc.$40K
- plus $61K from 5 others
What the payments were for
- Consulting fees$271,40055%
- Speaking & faculty fees$137,10628%
- Travel & lodging$51,47410%
- Food & beverage$34,7547%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 242 | $164,693 |
| Medical Device Business Services, Inc. | 69 | $98,150 |
| Acutus Medical, Inc. | 120 | $70,809 |
| Philips North America LLC | 30 | $40,797 |
| Biosense Webster, Inc. | 276 | $37,407 |
| Cardiofocus, Inc. | 4 | $24,876 |
| Volta Medical Inc | 12 | $17,312 |
| Abbott | 99 | $15,289 |
| Medtronic(2 entities) | 71 | $9,955 |
| Cvrx, Inc. | 32 | $7,220 |
| Sanofi-aventis U.S. LLC | 4 | $4,436 |
| Altathera Pharmaceuticals LLC | 3 | $1,142 |
| E.r. Squibb & Sons, L.L.C. | 11 | $450 |
| Impulse Dynamics (USA) Inc. | 8 | $402 |
| Johnson & Johnson(2 entities) | 10 | $331 |
| Atricure, Inc. | 4 | $260 |
| Vital Connect, Inc | 2 | $220 |
| Elutia, Inc. | 3 | $175 |
| Pfizer | 9 | $147 |
| Medicomp Inc | 1 | $137 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $126 |
| Amgen | 8 | $104 |
| Irhythm Technologies, Inc. | 4 | $70 |
| Akcea Therapeutics, Inc. | 4 | $62 |
| Novartis | 4 | $57 |
| Lantheus Medical Imaging, Inc. | 1 | $23 |
| Inari Medical, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$104,010
- WATCHMAN Access System$43,831
- GENERAL EP$35,313
- Watchman$25,627
- Carto 3 System$23,718
- IGT D Peripheral$20,250
- (9310) EPD KODEX Innovations software$18,511
- VX1$16,982
- Farapulse$15,171
- HeartLight System$12,381
- GENERAL - THERAPIES$8,793
- Barostim Neo System$6,437
- FARASTAR$5,625
- ENSITE PRECISION$5,158
- EMBLEM MRI S-ICD$4,014
- Reveal LINQ$2,691
- AVEIR$2,034
- PulseSelect$1,663
- GENERAL BRADY$1,500
- ENSITE$1,486
How this compares
$494,734 in reported general payments places this provider in the 95th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 434 | $334,849 |
| MultaqDronedarone Hcl | 94 | $90,334 |
| EntrestoSacubitril/Valsartan | 59 | $47,942 |
| XareltoRivaroxaban | 62 | $46,109 |
| Flecainide Acetate | 151 | $9,068 |
| Amiodarone Hcl | 205 | $4,388 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 16 | $3,095 |
| SotalolSotalol Hcl | 106 | $2,341 |
| Metoprolol Succinate | 86 | $1,803 |
| Sotalol AfSotalol Hcl | 16 | $573 |
| Carvedilol | 66 | $490 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 15 | $432 |
| Atorvastatin Calcium | 14 | $342 |
| Amlodipine Besylate | 28 | $336 |
| Bumetanide | 14 | $291 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $147 | $334,849434 claims |
| Sanofi-aventis U.S. LLCMultaq | $4,436 | $90,33494 claims |
| NovartisEntresto | $57 | $47,94259 claims |
| Johnson & JohnsonXarelto | $331 | $46,10962 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
Other clinical cardiac electrophysiology in Birmingham
- Hugh McElderryBirmingham$725K
- Gustavo MoralesBirmingham$171K
- William MaddoxBirmingham$159K
- Francis BennBirmingham$95K
- Terence DunnBirmingham$73K
- Byron ColleyBirmingham$59K
- Macy SmithBirmingham$45K
- Chad ColonBirmingham$42K
- Blake SmithBirmingham$36K
- Ahmad JalladBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.